Ambeed.cn

首页 / 抑制剂/激动剂 / 膜转运蛋白 / ATPase / KM91104

KM91104 {[allProObj[0].p_purity_real_show]}

货号:A1249487

KM91104是一种特异性的 v-ATPase 抑制剂,专门靶向 v-ATPase 亚基 a3 和亚基 B2 之间的相互作用。

KM91104 化学结构 CAS号:304481-60-5
KM91104 化学结构
CAS号:304481-60-5
KM91104 3D分子结构
CAS号:304481-60-5
KM91104 化学结构 CAS号:304481-60-5
KM91104 3D分子结构 CAS号:304481-60-5
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

KM91104 纯度/质量文件 产品仅供科研

货号:A1249487 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

JMC, 2024. Ambeed. [ A919389 , A918471 , A995972 ]
Anal. Chem., 2024, 96(50): 19947-19954. Ambeed. [ A261947 , A1165388 ]
ACS Biomater. Sci. Eng., 2024. Ambeed. [ A220462 ]
ACS Biomater. Sci. Eng., 2024. Ambeed. [ A165235 , A110205 ]
Pharmaceutics, 2024, 16(12): 1546. Ambeed. [ A272538 , A187261 , A691302 , A506702 ]
更多 >
产品名称 ATPase 其他靶点 纯度
(-)-Blebbistatin 99%+
PF 03716556 ++++

H+/K+-ATPase, pIC50: ~6.5

99%
Esomeprazole sodium 98%
BTB06584 99%
Ciclopirox 97%
CB-5083 ++++

p97 AAA ATPase, IC50: 11 nM

99%+
Ciclopirox olamine 99%
Brefeldin A +++

ATPase (HCT 116), IC50: 0.2 μM

99%+
Oligomycin A 99%
Sodium orthovanadate +++

(Na,K)-ATPase, IC50: 40 nM

99%
Golgicide A 99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

KM91104 生物活性

描述 The vacuolar H+ adenosine-triphosphatase (v-ATPase) multi-subunit complex is a key regulator of intracellular pH homeostasis. KM91104 is a cell-permeable inhibitor of v-ATPase. In hHSC (human hepatic stellate cells), KM91104 (1 nM and 10 nM; 48 hr) reduced v-ATPase expression and activity. Serum starved hHSC displayed a higher neutral red uptake compared to cells in complete medium reflecting a more acidic pH inside the lysosomes and endosomes. KM91104 (10 nM) in serum free condition reversed this effect as demonstrated by a decreased uptake of neutral red when compared to the control cells. Likewise, treatment with 10 nM KM91104 was followed by a significant decrease in cytosolic pH. Specific inhibition of v-ATPase with KM91104 induced a down-regulation of the HSC fibrogenic gene profile, which coincided with increased lysosomal pH, decreased pHi, activation of AMPK, reduced proliferation, and lower metabolic activity[3].
作用机制 KM91104 specifically targets the interaction between v-ATPase subunit a3 and subunit B2[3].

KM91104 参考文献

[1]Marrone G, De Chiara F, Böttcher K, Levi A, Dhar D, Longato L, Mazza G, Zhang Z, Marrali M, Fernández-Iglesias A, Hall A, Luong TV, Viollet B, Pinzani M, Rombouts K. The adenosine monophosphate-activated protein kinase-vacuolar adenosine triphosphatase-pH axis: A key regulator of the profibrogenic phenotype of human hepatic stellate cells. Hepatology. 2018 Sep;68(3):1140-1153. doi: 10.1002/hep.30029. Epub 2018 Jul 16. PMID: 29663481.

[2]Kartner N, Yao Y, Li K, Crasto GJ, Datti A, Manolson MF. Inhibition of osteoclast bone resorption by disrupting vacuolar H+-ATPase a3-B2 subunit interaction. J Biol Chem. 2010 Nov 26;285(48):37476-90. doi: 10.1074/jbc.M110.123281. Epub 2010 Sep 13. PMID: 20837476; PMCID: PMC2988353.

[3]Marrone G, et al. The adenosine monophosphate-activated protein kinase-vacuolar adenosine triphosphatase-pH axis: A key regulator of the profibrogenic phenotype of human hepatic stellate cells. Hepatology. 2018 Sep;68(3):1140-1153

KM91104 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.67mL

0.73mL

0.37mL

18.37mL

3.67mL

1.84mL

36.73mL

7.35mL

3.67mL

KM91104 技术信息

CAS号304481-60-5
分子式C14H12N2O4
分子量 272.256
别名
运输蓝冰
存储条件

In solvent -20°C:3-6个月-80°C:12个月

Pure form Sealed in dry,2-8°C

溶解方案

DMSO: 105 mg/mL(385.67 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案一
方案二
动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。